STOCK TITAN

FMR LLC discloses 9.7% stake in QuidelOrtho (NASDAQ: QDEL)

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

QuidelOrtho Corp was reported as having 6,591,151.54 shares beneficially owned by FMR LLC, representing 9.7% of the common stock as of 03/31/2026. The filing (Schedule 13G/A Amendment No. 2) lists sole dispositive power of 6,591,151.54 shares and sole voting power of 6,587,889 shares. The cover shows CUSIP 219798105 and identifies Abigail P. Johnson in a related reporting capacity.

Positive

  • None.

Negative

  • None.

Insights

FMR LLC holds a disclosed passive stake of 9.7% in QuidelOrtho as of 03/31/2026.

FMR LLC is reported with 6,591,151.54 shares of beneficial ownership and sole dispositive power over the same amount, indicating control over disposition decisions. The filing is an amendment to a Schedule 13G, a routine passive ownership disclosure under Section 13.

Key dependencies include any future amendments or Schedule 13D conversion if the position becomes active. Subsequent filings would show changes in percentage or voting/dispositive power.

Beneficial ownership 6,591,151.54 shares as of <date>03/31/2026</date>
Percent of class 9.7% reported on Schedule 13G/A Amendment No. 2
Sole voting power 6,587,889 shares as disclosed on the cover page
CUSIP 219798105 QuidelOrtho common stock identifier
Filing type Schedule 13G/A (Amendment No. 2) ownership disclosure
Schedule 13G/A regulatory
"Schedule 13G/A Amendment No. 2 on the cover page"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
Beneficially owned financial
"Amount beneficially owned: 6591151.54"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Sole dispositive power regulatory
"Sole power to dispose or to direct the disposition of: 6591151.54"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Power of Attorney legal
"Duly authorized under Power of Attorney effective as of April 13, 2026"
A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does FMR LLC report in QDEL?

FMR LLC reports beneficial ownership of 6,591,151.54 shares, equal to 9.7% of common stock. This figure is shown in the Schedule 13G/A Amendment No. 2 and is tied to the 03/31/2026 reporting period.

Who holds voting and dispositive power for the reported QDEL shares?

The filing lists sole voting power of 6,587,889 shares and sole dispositive power of 6,591,151.54 shares. Abigail P. Johnson is named in the filing in a related capacity linked to FMR LLC’s reporting.

What form was filed for this disclosure on QDEL?

The disclosure was made on a Schedule 13G/A (Amendment No. 2), which is used for passive investors reporting beneficial ownership above 5%. The cover shows CUSIP 219798105 and an as‑of date of 03/31/2026.

Does the filing identify any other persons with >5% interest in QDEL?

The Schedule 13G/A states that no other single person is known to have an interest exceeding 5%. It notes other persons may have rights to dividends or proceeds but none exceed the five percent threshold.

Who signed the Schedule 13G/A amendment for FMR LLC?

The amendment is signed by Richard Bourgelas as duly authorized under a Power of Attorney dated April 13, 2026, filing signatures dated 05/05/2026. The filing references an Exhibit 24 power of attorney.





219798105

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



FMR LLC
Signature:Richard Bourgelas
Name/Title:Duly authorized under Power of Attorney effective as of April 13, 2026, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Date:05/05/2026
Abigail P. Johnson
Signature:Richard Bourgelas
Name/Title:Duly authorized under Power of Attorney effective as of April 13, 2026, by and on behalf of Abigail P. Johnson*
Date:05/05/2026

Comments accompanying signature: *This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on April 29,2026, accession number: 0000315066-26-000738.
Exhibit Information

Please see Exhibit 99 for 13d-1(k) (1) agreement.